Stock 301080 ACROBIOSYSTEMS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Acrobiosystems Co.,Ltd.

Equities

301080

CNE100004S13

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 14/06/2024 am IST 		5-day change 1st Jan Change
37.54 CNY -3.07% Intraday chart for Acrobiosystems Co.,Ltd. +2.48% -36.31%
18/04 Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
10/04 ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Acrobiosystems Co.,Ltd. Approves Cash Dividend for 2023
CI
Acrobiosystems Co.,Ltd. Proposes Final Cash Dividend for 2023
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research
CI
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.
CI
Acrobiosystems Co.,Ltd.'s Equity Buyback announced on July 18, 2023, has closed with 273,800 shares, representing 0.23% for CNY 16 million.
CI
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.
CI
Acrobiosystems Launches Gmp Grade Dll4 Protein to Accelerate Stem Cell Manufacturing
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Acrobiosystems Co.,Ltd. Approves Board Elections
CI
Acrobiosystems Co.,Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.
CI
Acrobiosystems Co.,Ltd. authorizes a Buyback Plan.
CI
ACROBiosystems, Through ACRO Certify and Under its Aneuro Brand, Announces Launch of in Vivo Electrophysiology Solutions for Neuroscience Research with Diagnostic Biochips
CI
Acrobiosystems Co.,Ltd. Approves the Cash Dividend for the Year 2022, Payment Date: 07 June 2023
CI
Acrobiosystems Co.,Ltd. Approves the Cash Dividend for the Year 2022
CI
Acrobiosystems Co.,Ltd. Proposes Final Cash Dividend for the Year 2022
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
ACROBiosystems Launches New Logistics Center in Switzerland to Help Accelerate Drug Development Throughout Europe
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301080 Stock
  4. News Acrobiosystems Co.,Ltd.